Also known as: Glocally
AI Agents for Pharma Drug Launches
Company is active
Event Year: 2022
Company is active
Event Year: 2022
Cellbyte provides AI-powered agents designed to assist pharmaceutical companies in the global launch of new drugs. Their platform enables market-leading firms to gain critical insights, addressing key questions such as optimal pricing strategies for new drugs in different markets like the U.S. and Germany. The founding team brings a wealth of relevant experience to the table. Daniel's background includes over five years at Simon-Kucher, a prominent life sciences consultancy. Felix has a proven track record of closing substantial deals, including $3 million+ ACV contracts with major clients like H&M from his previous YC startup. Samuel's expertise lies in enterprise AI applications, honed through his MSc in Information Systems from TUM and his experience as an ML Engineer at Celonis.
Cellbyte provides AI-powered agents designed to assist pharmaceutical companies in the global launch of new drugs. Their platform enables market-leading firms to gain critical insights, addressing key questions such as optimal pricing strategies for new drugs in different markets like the U.S. and Germany. The founding team brings a wealth of relevant experience to the table. Daniel's background includes over five years at Simon-Kucher, a prominent life sciences consultancy. Felix has a proven track record of closing substantial deals, including $3 million+ ACV contracts with major clients like H&M from his previous YC startup. Samuel's expertise lies in enterprise AI applications, honed through his MSc in Information Systems from TUM and his experience as an ML Engineer at Celonis.
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2022
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2022
Healthcare
Healthcare
Healthcare -> Healthcare IT
Healthcare -> Healthcare IT
Team size: 3
Hiring: No
Team size: 3
Hiring: No